Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Langer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMJ Quality Improvement Reports|January 7, 2016
Improving Detection of IV Infiltrates in NeonatesColleen Driscoll Md, Melissa Langer, Susan Burke, et al.
Diagnostics (Basel, Switzerland)|May 15, 2020
Emerging Approaches for Fluorescence-Based Newborn Screening of MucopolysaccharidosesRajendra Singh, Shaileja Chopra, Carrie Graham, et al.
Heliyon|July 24, 2023
Comparison of NET quantification methods based on immunofluorescence microscopy: Hand-counting, semi-automated and automated evaluationsTimo Henneck, Christina Krüger, Andreas Nerlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Breast Cancer Research and Treatment|May 14, 2017
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancerKara N Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 3, 2019
Constitutive TNF-α signaling in neonates is essential for the development of tissue-resident leukocyte profiles at barrier sitesMarie Sophie Bickes, Sabine Pirr, Anna Sophie Heinemann, et al.
NPJ Breast Cancer|November 24, 2025
DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancerElizabeth M Chislock, Tien-Chi Pan, Dhruv Pant, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMJ Quality Improvement Reports|January 7, 2016
Improving Detection of IV Infiltrates in NeonatesColleen Driscoll Md, Melissa Langer, Susan Burke, et al.
Diagnostics (Basel, Switzerland)|May 15, 2020
Emerging Approaches for Fluorescence-Based Newborn Screening of MucopolysaccharidosesRajendra Singh, Shaileja Chopra, Carrie Graham, et al.
Heliyon|July 24, 2023
Comparison of NET quantification methods based on immunofluorescence microscopy: Hand-counting, semi-automated and automated evaluationsTimo Henneck, Christina Krüger, Andreas Nerlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Breast Cancer Research and Treatment|May 14, 2017
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancerKara N Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 3, 2019
Constitutive TNF-α signaling in neonates is essential for the development of tissue-resident leukocyte profiles at barrier sitesMarie Sophie Bickes, Sabine Pirr, Anna Sophie Heinemann, et al.
NPJ Breast Cancer|November 24, 2025
DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancerElizabeth M Chislock, Tien-Chi Pan, Dhruv Pant, et al.
Pageof 1